Status:
COMPLETED
Combination Statin, Acetylsalicylic Acid and Dutasteride Use in Prostate Cancer
Lead Sponsor:
University Health Network, Toronto
Conditions:
Prostate Cancer
Eligibility:
MALE
Brief Summary
The purpose of this study is to assess whether there is any interaction between statins, acetylsalicylic acid (ASA) and dutasteride on protection from prostate cancer, the development of high grade pr...
Detailed Description
A review of data collected from REDUCE (REduction by DUtasteride of prostate Cancer Events) study participants will be performed. Data required for the analysis includes: ethnicity, prostate specific ...
Eligibility Criteria
Inclusion
- Participants who received dutasteride or placebo and had at least one post-baseline prostate biopsy
Exclusion
- Participants not taking concomitant statins or ASA
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
8231 Patients enrolled
Trial Details
Trial ID
NCT01428869
Start Date
August 1 2011
End Date
August 1 2011
Last Update
September 9 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada, M5G 2M9